WST250516P200000
- 2.55
- +0.20+8.51%
West Pharmaceutical Services Newsroom
Here's Why West Pharmaceutical Services (WST) Stock Fell 38%
West Pharmaceutical Services First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
West Pharmaceutical Services To Go Ex-Dividend On April 30th, 2025 With 0.21 USD Dividend Per Share
When Should You Buy West Pharmaceutical Services, Inc. (NYSE:WST)?
Executive Reshuffles: NNDM, BSX, and APPN
Jefferies Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Cuts Target Price to $245
West Pharmaceutical Services Earnings Call: Mixed Sentiments and Strategic Shifts
West Pharmaceutical Services Inc. Stock Outperforms Competitors On Strong Trading Day
Research Alert: CFRA Keeps Hold Opinion On Shares Of West Pharmaceutical Services, Inc.
Express News | West Pharmaceutical Services Inc : Jefferies Raises Target Price to $245 From $240
West Pharmaceutical Services To Go Ex-Dividend On July 30th, 2025 With 0.21 USD Dividend Per Share
West Pharmaceutical Services | 10-Q: Q1 2025 Earnings Report
Earnings Call Summary | West Pharmaceutical Services(WST.US) Q1 2025 Earnings Conference
West Pharmaceutical Defies Doubters: EPS Jumps, Outlook Raised Despite Tariff Drag
West Pharmaceutical Increases FY 2025 Revenue Guidance to $2.975B
West Pharmaceutical Services Shares Are Trading Lower After the Company Reported Q1 Financial Results and Cut Its FY25 EPS Guidance With Its Midpoint Below Estimates.
Express News | West Pharmaceutical Services Shares Down 4.4% After Co Lowers Hvp Components Business Forecast
Research Alert: Wst Beats Expectations In Q1, Posting Strong Free Cash Flow
Express News | West Pharmaceutical Services Exec Says Q2 Adj EPS Forecast Is $1.50 to $1.55 - Conf Call
William Blair Maintains West Pharmaceutical Services(WST.US) With Buy Rating